Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from TP53 mutations orchestrate partial EMT states in oral squamous cell carcinoma: spatially resolved and in vitro preliminary insights into tumour plasticity. Local targets link to admitted publications; unresolved targets remain external evidence.
Oral squamous cell carcinoma: review of prognostic and predictive factors
10.1016/j.tripleo.2005.07.038 · 2006 · External reference
Whole‐exome sequencing analysis of oral squamous cell carcinoma delineated by tobacco usage habits
10.3389/fonc.2021.660696 · 2021 · External reference
Biological significance of tumor heterogeneity in esophageal squamous cell carcinoma
10.3390/cancers11081156 · 2019 · External reference
A single‐cell atlas of the tumor and immune ecosystem of human breast cancer
10.1016/j.cell.2019.03.005 · 2019 · External reference
Targeting the DNA damage response in OSCC with TP53 mutations
10.1177/0022034518759068 · 2018 · External reference
Targeting p53 pathways: mechanisms, structures, and advances in therapy
10.1038/s41392-023-01347-1 · 2023 · External reference
Mutant p53 in cancer: new functions and therapeutic opportunities
10.1016/j.ccr.2014.01.021 · 2014 · External reference
TP53 mutations in head and neck cancer
10.1002/mc.23385 · 2022 · External reference
Biomarkers of epithelial–mesenchymal transition in squamous cell carcinoma
10.1177/0022034512467352 · 2013 · External reference
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
10.1038/s41580-018-0080-4 · 2019 · External reference
Epithelial–mesenchymal transition in cancer: a historical overview
10.1016/j.tranon.2020.100773 · 2020 · External reference
Partial EMT in head and neck cancer biology: a spectrum instead of a switch
10.1038/s41388-021-01868-5 · 2021 · External reference
Mutant p53 gain‐of‐function induces epithelial–mesenchymal transition through modulation of the miR‐130b–ZEB1 axis
10.1038/onc.2012.334 · 2013 · External reference
Fast and accurate short read alignment with Burrows–Wheeler transform
10.1093/bioinformatics/btp324 · 2009 · External reference
Strelka2: fast and accurate calling of germline and somatic variants
10.1038/s41592-018-0051-x · 2018 · External reference
VarScan: variant detection in massively parallel sequencing of individual and pooled samples
10.1093/bioinformatics/btp373 · 2009 · External reference
10.3389/fgene.2022.979928
10.3389/fgene.2022.979928 · External reference
ANNOVAR: functional annotation of genetic variants from high‐throughput sequencing data
10.1093/nar/gkq603 · 2010 · External reference
EMT: 2016
10.1016/j.cell.2016.06.028 · 2016 · External reference
Epithelial–mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
10.15252/emmm.201404208 · 2014 · External reference
Human keratinocytes that express hTERT and also bypass a p16INK4a‐enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics
10.1128/mcb.20.4.1436-1447.2000 · 2000 · External reference
The desmosomal cadherin desmoglein‐3 acts as a keratinocyte anti‐stress protein via suppression of p53
10.1038/s41419-019-1988-0 · 2019 · External reference
Analysis of TP53 mutation status in human cancer cell lines: a reassessment
10.1002/humu.22556 · 2014 · External reference
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
10.1038/s41419-022-05408-1 · 2022 · External reference
Somatic mutations in oral squamous cell carcinomas in 98 Japanese patients and their clinical implications
2021 · External reference
High‐risk TP53 mutations are associated with extranodal extension in oral cavity squamous cell carcinoma
10.1158/1078-0432.ccr-17-0721 · 2018 · External reference
Comprehensive genomic characterization of head and neck squamous cell carcinomas
10.1038/nature14129 · 2015 · External reference
Dominant‐negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma cells
10.2220/biomedres.40.37 · 2019 · External reference
Partial‐EMT in oral squamous cell carcinoma: molecular circuitry and clinical translation
10.1038/s41368-025-00417-0 · 2026 · External reference
Partial EMT in squamous cell carcinoma: a snapshot
10.7150/ijbs.61566 · 2021 · External reference
Opposing roles of wild‐type and mutant p53 in the process of epithelial to mesenchymal transition
10.3389/fmolb.2022.928399 · 2022 · External reference
Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma
10.1002/cncr.33101 · 2020 · External reference
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
10.1056/nejmoa1113205 · 2012 · External reference
Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma
10.1038/ng.3683 · 2016 · External reference
Expression of epithelial–mesenchymal transition‐related markers in triple‐negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome
10.1016/j.humpath.2015.05.010 · 2015 · External reference
EMT transition states during tumor progression and metastasis
10.1016/j.tcb.2018.12.001 · 2019 · External reference
Mutant p53 drives invasion by promoting integrin recycling
10.1016/j.cell.2009.11.026 · 2009 · External reference
